Total Funding
75
79
Total FundingSeed raised
Growth Score 75 in past quarter
-9 pts
Heat Score 79 in past quarter
18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
66621
Healome Therapeutics is a healthcare company that develops treatments for ocular surface diseases.
- Liam Grover: Co-FounderPast Role: University of Birmingham, Lecturer in Chemical Engineering
- Richard Williams: CEO and Co-FounderPast Role: National Institute for Health and Care Research, Surgical Reconstruction and Microbiology Research Centre Research Fellow
About the Company
Healome Therapeutics is a healthcare company that develops treatments for ocular surface diseases. Healome Therapeutics creates 'pro-healing' microenvironments to address some of the most difficult conditions known to have biological, chemical, and physical drivers, as well as significant therapeutic delivery and retention challenges.